Molecular complexity of intraductal carcinoma of the prostate
© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd..
Intraductal carcinoma of the prostate (IDC-P) is an aggressive subtype of prostate cancer characterized by the growth of tumor cells within the prostate ducts. It is often found alongside invasive carcinoma and is associated with poor prognosis. Understanding the molecular mechanisms driving IDC-P is crucial for improved diagnosis, prognosis, and treatment strategies. This review summarizes the molecular characteristics of IDC-P and their prognostic indications, comparing them to conventional prostate acinar adenocarcinoma, to gain insights into its unique behavior and identify potential therapeutic targets.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Cancer medicine - 13(2024), 2 vom: 19. Jan., Seite e6939 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhu, Sha [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 22.02.2024 Date Revised 24.02.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/cam4.6939 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368693511 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368693511 | ||
| 003 | DE-627 | ||
| 005 | 20240229150203.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240222s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cam4.6939 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1304.xml |
| 035 | |a (DE-627)NLM368693511 | ||
| 035 | |a (NLM)38379333 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhu, Sha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Molecular complexity of intraductal carcinoma of the prostate |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.02.2024 | ||
| 500 | |a Date Revised 24.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. | ||
| 520 | |a Intraductal carcinoma of the prostate (IDC-P) is an aggressive subtype of prostate cancer characterized by the growth of tumor cells within the prostate ducts. It is often found alongside invasive carcinoma and is associated with poor prognosis. Understanding the molecular mechanisms driving IDC-P is crucial for improved diagnosis, prognosis, and treatment strategies. This review summarizes the molecular characteristics of IDC-P and their prognostic indications, comparing them to conventional prostate acinar adenocarcinoma, to gain insights into its unique behavior and identify potential therapeutic targets | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a DNA damage and repair | |
| 650 | 4 | |a Intraductal carcinoma of the prostate | |
| 650 | 4 | |a MED12 | |
| 650 | 4 | |a MYC | |
| 650 | 4 | |a NCOR2 | |
| 650 | 4 | |a PTEN | |
| 650 | 4 | |a RB1 | |
| 650 | 4 | |a SChLAP1 | |
| 650 | 4 | |a TMPRSS2-ERG fusion | |
| 650 | 4 | |a TP53 | |
| 650 | 4 | |a molecular characteristics | |
| 650 | 4 | |a prostate acinar adenocarcinoma | |
| 650 | 4 | |a targeted therapy | |
| 700 | 1 | |a Xu, Nanwei |e verfasserin |4 aut | |
| 700 | 1 | |a Zeng, Hao |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer medicine |d 2012 |g 13(2024), 2 vom: 19. Jan., Seite e6939 |w (DE-627)NLM224388460 |x 2045-7634 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2024 |g number:2 |g day:19 |g month:01 |g pages:e6939 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/cam4.6939 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2024 |e 2 |b 19 |c 01 |h e6939 | ||